Clinical trials of anti thrombotic therapy require a cohesive assessment of benefit and risk. A new graphical method to represent the bivariate relation of benefit and risk in trials of anti thrombotic drugs is de-scribed and illustrated using published data from the four major registration clinical trials of non-vitamin K oral anticoagulants (NOACs) totaling 71,683…